BioNTech’s mRNA vaccine drive now includes malaria, TB shotsFlushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots Share XBioNTech’s mRNA vaccine drive now includes malaria, TB shotshttps://pharmaphorum.com/news/biontechs-mrna-vaccine-drive-now-includes-malaria-tb-shots/
Elliott fires broadside at GSK in wake of investor updateGlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm’s prospects at Share XElliott fires broadside at GSK in wake of investor updatehttps://pharmaphorum.com/news/elliott-fires-broadside-at-gsk-in-wake-of-investor-update/
What HCPs think about blood clots linked to COVID-19 vaccinesIn the latest edition of What HCPs Think, CREATION.co’s Laura Marsh looks at what healthcare professionals are saying about Share XWhat HCPs think about blood clots linked to COVID-19 vaccineshttps://pharmaphorum.com/views-and-analysis/what-hcps-think-about-blood-clots-linked-to-covid-19-vaccines/
UK ‘planning to widen AstraZeneca COVID jab restrictions’Reports are emerging that the UK may join other countries in imposing restrictions on the use of AstraZeneca’s Share XUK ‘planning to widen AstraZeneca COVID jab restrictions’https://pharmaphorum.com/news/uk-planning-to-widen-astrazeneca-covid-jab-restrictions/
Creating a global life sciences superpower from the lessons of COVIDIt’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry Share XCreating a global life sciences superpower from the lessons of COVIDhttps://pharmaphorum.com/views-and-analysis/creating-a-global-life-sciences-superpower-from-the-lessons-of-covid-uk/
Not just COVID-19 vaccines: 5 things that cause blood clotsReports of COVID-19 vaccinations causing blood clots has caused alarm in the general population. However due to the Share XNot just COVID-19 vaccines: 5 things that cause blood clotshttps://pharmaphorum.com/views-and-analysis/5-things-that-cause-blood-clots/
GlaxoSmithKline focuses on split after lacklustre Q1 resultsGlaxoSmithKline’s CEO Emma Walmsley said the company is focused on pursuing its strategy to spin off its consumer Share XGlaxoSmithKline focuses on split after lacklustre Q1 resultshttps://pharmaphorum.com/news/glaxosmithkline-focuses-on-split-after-lacklustre-q1-results/
GSK on COVID and vaccine development: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery Share XGSK on COVID and vaccine development: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-covid-vaccines
Doubts emerge over AZ’s ‘outdated’ US vaccine trial dataAstraZeneca has been rebuked by a US health authority after a trial monitoring board said data published from Share XDoubts emerge over AZ’s ‘outdated’ US vaccine trial datahttps://pharmaphorum.com/news/doubts-emerge-over-azs-outdated-us-vaccine-trial-data/
